Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Filgrastim vs Pegfilgrastim in Breast Cancer
NCT02685111Phase 2Terminated
- Sponsor
- Asan Medical Center
- Start
- Feb 2016
- Primary completion
- Dec 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in febrile neutropenia (FN), sponsored by Asan Medical Center. Started Feb 2016; status: terminated.
02
Drugs
filgrastim
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT02685111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685111.